The Promise and Challenge of Big Data for Pharma
Harvard Business
NOVEMBER 29, 2016
One of the biggest is how to make the transition from legacy technology and analytical competence to more-powerful and sophisticated analytical tools and analysis methodologies. While these advances are generating great opportunities, they also pose resourcing and capability development challenges. Genentech, which is owned by F.
Let's personalize your content